Bergmann Anthony has filed 21 insider transactions across 1 company since October 2013.
Most recent transaction: a option exercise of 3000 shares of CAPRICOR THERAPEUTICS, INC. ($CAPR) on May 18, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | M | Stock Option (Right to Buy) | 3000 | $0.00 | 0.0000 | 57,434,267 | 100.00% | 0.01% |
| May 18, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | M | Common Stock | 3000 | $1.39 | 11,223.0000 | 57,434,267 | 36.48% | 0.01% |
| May 1, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | M | Common Stock | 25000 | $3.18 | 33,223.0000 | 46,478,416 | 304.03% | 0.05% |
| May 1, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | M | Stock Option (Right to Buy) | 25000 | $0.00 | 116,980.0000 | 46,478,416 | 17.61% | 0.05% |
| May 1, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | S | Common Stock | 25000 | $31.70 | 8,223.0000 | 46,478,416 | 75.25% | 0.05% |
| March 31, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | S | Common Stock | 25000 | $30.13 | 8,223.0000 | 46,478,416 | 75.25% | 0.05% |
| March 31, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | M | Stock Option (Right to Buy) | 25000 | $0.00 | 141,980.0000 | 46,478,416 | 14.97% | 0.05% |
| March 31, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | M | Common Stock | 25000 | $3.18 | 33,223.0000 | 46,478,416 | 304.03% | 0.05% |
| Jan. 5, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 45,716,151 | 9999.99% | 0.05% |
| Jan. 5, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 45,716,151 | 9999.99% | 0.05% |
| Jan. 5, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 2500 | $0.00 | 2,500.0000 | 45,716,151 | 9999.99% | 0.01% |
| March 3, 2025 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | M | Common Stock | 2500 | $1.39 | 8,223.0000 | 35,218,628 | 43.68% | 0.01% |
| March 3, 2025 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | M | Stock Option (Right to Buy) | 2500 | $0.00 | 0.0000 | 35,218,628 | 100.00% | 0.01% |
| Jan. 2, 2025 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | A | Common Stock | 3342 | $0.00 | 5,723.0000 | 35,218,628 | 140.36% | 0.01% |
| Jan. 2, 2025 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 6170 | $0.00 | 6,170.0000 | 35,218,628 | 9999.99% | 0.02% |
| Jan. 2, 2025 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 35,218,628 | 9999.99% | 0.21% |
| Jan. 2, 2024 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 26,778,360 | 9999.99% | 0.32% |
| Jan. 2, 2024 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 9692 | $0.00 | 9,692.0000 | 26,778,360 | 9999.99% | 0.04% |
| Oct. 23, 2013 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | M | Stock Option (Right to Buy) | 2178 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 23, 2023 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | M | Common Stock | 2178 | $1.39 | 2,381.0000 | 25,817,676 | 1072.91% | 0.01% |
| Jan. 3, 2023 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Bergmann Anthony | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 24,552,688 | 9999.99% | 0.35% |